Yehia Hashad

Yehia Hashad

Chief Tech/Sci/R&D Officer at BAUSCH + LOMB CORPORATION

Net worth: 3 M $ as of 29/06/2026

59 year
Health Technology
Consumer Services
Commercial Services

Profile

Yehia Hashad is currently a Member-Executive Board at Reeve-Irvine Research Center, Chief Medical Officer & EVP-Research & Development at Bausch + Lomb Corp.
since 2022, and Senior VP & Global Head-Research & Development at Allergen Aesthetics since 2020.
Former positions include Director at Beacon Therapeutics (USA), Inc. from 2021 to 2022, Director at National Alliance for Eye & Vision Research, Director at Unity Biotechnology, Inc. in 2025, Director at Glaucoma Research Foundation, and VP & Global Head-Ophthalmology Therapeutic Areas at Allergan, Inc. from 2010 to 2019.
Education includes undergraduate studies at INSEAD.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/05/2026 166,377 ( 0.05% ) 3 M $ 29/06/2026

Yehia Hashad active positions

CompaniesPositionStart
BAUSCH + LOMB CORPORATION Chief Tech/Sci/R&D Officer 30/01/2022
Allergen Aesthetics
Chief Tech/Sci/R&D Officer 30/04/2020
Reeve-Irvine Research Center
Corporate Officer/Principal -

Former positions of Yehia Hashad

CompaniesPositionEnd
UNITY BIOTECHNOLOGY, INC. Director/Board Member 26/06/2025
APPLIED GENETIC TECHNOLOGIES CORPORATION Director/Board Member 30/11/2022
ALLERGAN, INC. Corporate Officer/Principal 31/03/2019
National Alliance for Eye & Vision Research
Director/Board Member -
Director/Board Member -
See the detail of Yehia Hashad's experience

Training of Yehia Hashad

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

National Alliance for Eye & Vision Research

Commercial Services

Health Technology

Reeve-Irvine Research Center

Health Technology

Allergen Aesthetics